849 related articles for article (PubMed ID: 32220583)
1. MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcohol-associated fatty liver and steatohepatitis.
Wu X; Poulsen KL; Sanz-Garcia C; Huang E; McMullen MR; Roychowdhury S; Dasarathy S; Nagy LE
J Hepatol; 2020 Sep; 73(3):616-627. PubMed ID: 32220583
[TBL] [Abstract][Full Text] [Related]
2. MLKL contributes to Western diet-induced liver injury through inhibiting autophagy.
Wu X; Nagy LE
Autophagy; 2020 Jul; 16(7):1351-1352. PubMed ID: 32403970
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.
Majdi A; Aoudjehane L; Ratziu V; Islam T; Afonso MB; Conti F; Mestiri T; Lagouge M; Foufelle F; Ballenghien F; Ledent T; Moldes M; Cadoret A; Fouassier L; Delaunay JL; Aït-Slimane T; Courtois G; Fève B; Scatton O; Prip-Buus C; Rodrigues CMP; Housset C; Gautheron J
J Hepatol; 2020 Apr; 72(4):627-635. PubMed ID: 31760070
[TBL] [Abstract][Full Text] [Related]
4. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
[TBL] [Abstract][Full Text] [Related]
5. Receptor-interacting protein 1 and 3 kinase activity are required for high-fat diet induced liver injury in mice.
Wu X; Arya RK; Huang E; McMullen MR; Nagy LE
Front Endocrinol (Lausanne); 2023; 14():1267996. PubMed ID: 38161978
[TBL] [Abstract][Full Text] [Related]
6. Differential role of MLKL in alcohol-associated and non-alcohol-associated fatty liver diseases in mice and humans.
Miyata T; Wu X; Fan X; Huang E; Sanz-Garcia C; Ross CKC; Roychowdhury S; Bellar A; McMullen MR; Dasarathy J; Allende DS; Caballeria J; Sancho-Bru P; McClain CJ; Mitchell M; McCullough AJ; Radaeva S; Barton B; Szabo G; Dasarathy S; Nagy LE
JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33616081
[TBL] [Abstract][Full Text] [Related]
7. Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD.
González-Rodríguez A; Mayoral R; Agra N; Valdecantos MP; Pardo V; Miquilena-Colina ME; Vargas-Castrillón J; Lo Iacono O; Corazzari M; Fimia GM; Piacentini M; Muntané J; Boscá L; García-Monzón C; Martín-Sanz P; Valverde ÁM
Cell Death Dis; 2014 Apr; 5(4):e1179. PubMed ID: 24743734
[TBL] [Abstract][Full Text] [Related]
8. CAMK2/CaMKII activates MLKL in short-term starvation to facilitate autophagic flux.
Zhan Q; Jeon J; Li Y; Huang Y; Xiong J; Wang Q; Xu TL; Li Y; Ji FH; Du G; Zhu MX
Autophagy; 2022 Apr; 18(4):726-744. PubMed ID: 34282994
[TBL] [Abstract][Full Text] [Related]
9. Autophagy activation by Jiang Zhi Granule protects against metabolic stress-induced hepatocyte injury.
Zheng YY; Wang M; Shu XB; Zheng PY; Ji G
World J Gastroenterol; 2018 Mar; 24(9):992-1003. PubMed ID: 29531463
[TBL] [Abstract][Full Text] [Related]
10. The role of MLKL in Hepatic Ischemia-Reperfusion Injury of Alcoholic Steatotic Livers.
Chen H; McKeen T; Chao X; Chen A; Deng F; Jaeschke H; Ding WX; Ni HM
Int J Biol Sci; 2022; 18(3):1096-1106. PubMed ID: 35173541
[TBL] [Abstract][Full Text] [Related]
11. Palmitic acid induces autophagy in hepatocytes via JNK2 activation.
Tu QQ; Zheng RY; Li J; Hu L; Chang YX; Li L; Li MH; Wang RY; Huang DD; Wu MC; Hu HP; Chen L; Wang HY
Acta Pharmacol Sin; 2014 Apr; 35(4):504-12. PubMed ID: 24608675
[TBL] [Abstract][Full Text] [Related]
12. Mismatched effects of receptor interacting protein kinase-3 on hepatic steatosis and inflammation in non-alcoholic fatty liver disease.
Saeed WK; Jun DW; Jang K; Ahn SB; Oh JH; Chae YJ; Lee JS; Kang HT
World J Gastroenterol; 2018 Dec; 24(48):5477-5490. PubMed ID: 30622377
[TBL] [Abstract][Full Text] [Related]
13. Receptor interacting protein 3 protects mice from high-fat diet-induced liver injury.
Roychowdhury S; McCullough RL; Sanz-Garcia C; Saikia P; Alkhouri N; Matloob A; Pollard KA; McMullen MR; Croniger CM; Nagy LE
Hepatology; 2016 Nov; 64(5):1518-1533. PubMed ID: 27301788
[TBL] [Abstract][Full Text] [Related]
14. Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling.
Chen W; Zhou Z; Li L; Zhong CQ; Zheng X; Wu X; Zhang Y; Ma H; Huang D; Li W; Xia Z; Han J
J Biol Chem; 2013 Jun; 288(23):16247-16261. PubMed ID: 23612963
[TBL] [Abstract][Full Text] [Related]
15. Decrease in fat de novo synthesis and chemokine ligand expression in non-alcoholic fatty liver disease caused by inhibition of mixed lineage kinase domain-like pseudokinase.
Saeed WK; Jun DW; Jang K; Oh JH; Chae YJ; Lee JS; Koh DH; Kang HT
J Gastroenterol Hepatol; 2019 Dec; 34(12):2206-2218. PubMed ID: 31132314
[TBL] [Abstract][Full Text] [Related]
16. The pseudokinase MLKL regulates hepatic insulin sensitivity independently of inflammation.
Xu H; Du X; Liu G; Huang S; Du W; Zou S; Tang D; Fan C; Xie Y; Wei Y; Tian Y; Fu X
Mol Metab; 2019 May; 23():14-23. PubMed ID: 30837196
[TBL] [Abstract][Full Text] [Related]
17. Activated MLKL attenuates autophagy following its translocation to intracellular membranes.
Frank D; Vaux DL; Murphy JM; Vince JE; Lindqvist LM
J Cell Sci; 2019 Feb; 132(5):. PubMed ID: 30709919
[TBL] [Abstract][Full Text] [Related]
18. Hepatic autophagy fluctuates during the development of non-alcoholic fatty liver disease.
Ding H; Ge G; Tseng Y; Ma Y; Zhang J; Liu J
Ann Hepatol; 2020; 19(5):516-522. PubMed ID: 32553647
[TBL] [Abstract][Full Text] [Related]
19. Macrophage-derived MLKL in alcohol-associated liver disease: Regulation of phagocytosis.
Wu X; Fan X; McMullen MR; Miyata T; Kim A; Pathak V; Wu J; Day LZ; Hardesty JE; Welch N; Dasarathy J; Allende DS; McCullough AJ; Jacobs JM; Rotroff DM; Dasarathy S; Nagy LE
Hepatology; 2023 Mar; 77(3):902-919. PubMed ID: 35689613
[TBL] [Abstract][Full Text] [Related]
20. Effects of Hsp90 inhibitor on the RIP1-RIP3-MLKL pathway during the development of heart failure in mice.
Marunouchi T; Nishiumi C; Iinuma S; Yano E; Tanonaka K
Eur J Pharmacol; 2021 May; 898():173987. PubMed ID: 33640405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
